Navigation Links
BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
Date:1/6/2012

cipate in the call which can be accessed at www.bdsi.com or toll-free at (866) 516-3002 or at (760) 298-5082.  For those who are not able to listen to the live broadcast, a replay of the call will be made available on the BDSI website.

About BioDelivery Sciences International

BioDelivery Sciences International (NASDAQ: BDSI) is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, new applications of proven therapeutics.  BDSI is focusing on developing products to meet unmet patient needs in the areas of pain management and oncology supportive care.  BDSI's pain franchise currently consists of two products utilizing the patented BEMA technology.  ONSOLIS (fentanyl buccal soluble film) is approved in the U.S., Canada, and the E.U. (where it will be marketed as BREAKYL), for the management of breakthrough pain in opioid tolerant, adult patients with cancer.  The commercial rights are licensed to Meda for all territories worldwide except for Taiwan (licensed to TTY Biopharm) and South Korea (licensed to Kunwha Pharmaceutical Co.).  BDSI's second pain product, BEMA Buprenorphine, is being developed for the treatment of moderate to severe chronic pain and is in development in a high dose formulation with naloxone for the treatment of opioid dependence.  BEMA Buprenorphine for chronic pain is licensed on a worldwide basis to Endo Pharmaceuticals.  Additional product candidates are being developed utilizing the BEMA technology for conditions such as nausea/vomiting (BEMA Granisetron).  BDSI's headquarters is located in Raleigh, North Carolina.  For more information, visit www.bdsi.com.

BDSI® and
'/>"/>

SOURCE BioDelivery Sciences International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study
2. BioDelivery Sciences to Host Business Update Webcast and Conference Call on Tuesday, November 15, 2011 at 8:30 AM Eastern Time
3. BioDelivery Sciences Initiates Confirmatory Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
4. Samuel J. Sears, Jr. Appointed to BioDelivery Sciences Board of Directors
5. BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence
6. BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences
7. BioDelivery Sciences Announces Commercial Launch of ONSOLIS in Canada
8. BioDelivery Sciences to Present at the Jeffries Global Healthcare Conference
9. BioDelivery Sciences Provides Update on Status of Modified REMS Program for ONSOLIS
10. BioDelivery Sciences Announces Completion of Recruitment in BEMA Buprenorphine Phase 3 Chronic Pain Study
11. BioDelivery Sciences to Present at the 23rd Annual ROTH OC Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... DURECT Corporation (Nasdaq: DRRX ) announced ... upcoming healthcare conferences.  , James ... the Rodman & Renshaw Investment Conference on Thursday, September ... being held at the St. Regis Hotel in ... webcast of the presentation will be available by accessing ...
(Date:8/27/2015)... 2015 ieCrowd™ today announced the achievement ... of the company,s supplemental oxygen delivery device, Smart ... developed by ieCrowd,s subsidiary Smart Oxygen Solutions TM ... for oxygen based on level of activity.  The ... the Smart Oxygen device would require a series ...
(Date:8/27/2015)... , Aug. 27, 2015  Eli Lilly and ... Stanley Global Healthcare Conference on Thursday, September 17, 2015. ... president of Lilly Oncology and Richard Gaynor , ... affairs for Lilly Oncology, will participate in a fireside ... A live audio webcast will be available on ...
Breaking Medicine Technology:DURECT to Participate in Upcoming Healthcare Conferences 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4Lilly to Participate in Morgan Stanley Global Healthcare Conference 2
... Amgen (NASDAQ: AMGN ) will participate in the ... New York Palace Hotel in New York City, beginning at ... Relations at Amgen, will present. Live audio of the presentation ... www.amgen.com , under Investors. About ...
... Hospira, Inc. (NYSE: HSP ), ... positive results from a Phase I U.S. clinical trial ... (kidney) dysfunction who have anemia. Hospira,s trial met its ... distribution in the body, for Hospira,s EPO and the ...
Cached Medicine Technology:Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 2Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients 3
(Date:8/28/2015)... ... August 28, 2015 , ... ... loyalty at a low cost. Personalized with practice contact information and logos, Calendars ... Dental offices can also incorporate Calendars into seasonal mailings, thank you and welcome ...
(Date:8/28/2015)... ... 2015 , ... SharkNinja, an innovative leader in the housewares ... Sofia Vergara, and unveil the Ninja® brand’s new coffee machine, the Ninja ... variety of sizes and styles while achieving the perfect brew richness level every ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... added comprehensive information on two new duals programs: Rhode Island Integrated Care ... and Idaho’s partnership to revamp Blue Cross of Idaho’s D-SNP. The database ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Plaintiffs ... as MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in the midst ... custodial files the PSC may receive for corporate employees involved in the production ...
(Date:8/28/2015)... ... August 28, 2015 , ... Super-Sod launched their new website this ... most notable change is the responsive web design. Website users will now have an ... submit quote requests for sod, sign-up for the monthly turf-tips email, and find a ...
Breaking Medicine News(10 mins):Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3Health News:AIS Duals Database: August Update Finds Two New Duals Programs in Rhode Island and Idaho 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4
... treatment for Peripheral Artery DiseaseAUSTIN, Texas, Jan. 8 ... is the first hospital in the world to ... to successfully treat chronic total occlusions (CTOs), or ... Heart interventional cardiologist, Frank Zidar, M.D. used the ...
... MEMPHIS, Tenn., Jan. 8 St. Jude Children,s Research,Hospital(R) ... has increased his commitment to Eagles for St. Jude ... St. Jude for every eagle he,cards on the 2009 ... powerful program that,has united Villegas, FedExCup Champion Vijay Singh ...
... to Terrorist Missile StrikesNEW YORK, Jan. 8 ... North America today committed to raise $10 million to ... of a major initiative to support and stand in ... the terrorist organization in control of the Gaza Strip. ...
... Jan. 8 The National eHealth Collaborative, formerly AHIC ... leadership elections in which Kevin Hutchinson, President and CEO ... Chair of the organization,s 2009 Board of Directors. ... Health Information Community (AHIC), a federal advisory committee established ...
... Wyeth (NYSE: WYE ) announced today that ... on Wednesday, January 14, 2009 at 11:30 a.m. Eastern ... President, U.S. and Pharmaceutical Business Units, Wyeth Pharmaceuticals. Wyeth,s ... www.wyeth.com and available for replay following the conference.Wyeth ...
... ColiseumNEW YORK, Jan. 8 Stand Up for a Cure ... a Valentine,s Day show with Barry Manilow , in partnership ... held on February 14th, 2009 at Nassau Coliseum, and tickets for ... or by calling Stand Up for a Cure at 212 209 ...
Cached Medicine News:Health News:Heart Hospital of Austin First in World to Use New Device for Blocked Arteries 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 2Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 3Health News:Not to be Outdone by FedExCup Champion Vijay Singh, FedExCup Runner-Up Camilo Villegas Increases Commitment to Children of St. Jude 4Health News:UJC and Jewish Federations of North America Commit $10 Million for Needs in Southern Israel 2Health News:Kevin Hutchinson Elected Vice Chair of Board of Directors for National eHealth Collaborative 2Health News:Wyeth to Present at the JP Morgan Healthcare Conference 2Health News:Barry Manilow Brings Valentine's and Music to New York With Concert to Raise Funds for Breast Cancer Research 2
... The introduction of the AMO ... in Phaco technology; The combination of ... in complete control of fluidic conditions ... as the "smart Pump" orchestrates the ...
... The Catalyst system introduces a ... precision to microsurgical instrumentation. It ... digital design with advanced microcomputer ... simple to operate with a ...
The CV-12000 provides the surgeon with all the options to perform today's newest techniques....
Compact ultrasonic phacoemulsification system....
Medicine Products: